Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...

As a player in the growing telehealth sector, Hims & Hers Health ($HIMS) has grown significantly, driving its stock up over ...

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Since then, Hims & Hers has released a stunning quarterly report, and yet its stock has declined by more than 20%. In today's report, we will re-evaluate Hims & Hers Health to formulate an ...

After starting it in February, I noticed regrowth around the temples by June and thicker, stronger hair overall by August.” ...

Margins are typically high for HIMS treatments, as the company uses a network of compounding pharmacies to fulfill prescriptions at low cost, and churn is very low because obesity, anxiety ...

The newest drugs and treatments for rheumatoid arthritis (RA) include Janus kinase (JAK) inhibitors, a Bruton’s tyrosine kinase (BTK) inhibitor, and neurostimulation, among other treatments.

We recently compiled a list of the 10 Best Hair Care Stocks To Buy Now. In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against the other hair ...

We recently compiled a list of the 10 Best Hair Care Stocks To Buy Now. In this article, we are going to take a look at where ...

This regrowth treatment is formulated with 5 percent ... Why wait to finally get a handle on your hair loss? With Hims, the solution is just a few clicks away.